Fresenius Medical Care AG & Co. KGaA (FMS)

FMS Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	483.59	499	673.41	969.31	1,164	1,200
Depreciation & Amortization	1,827	1,752	1,838	1,624	1,786	1,593
Share-Based Compensation	-	0	0	0	0	1.99
Other Operating Activities	303.08	377.83	-344.39	-103.49	1,283	-227.82
Operating Cash Flow	2,613	2,629	2,167	2,489	4,233	2,567
Operating Cash Flow Growth	21.46%	21.29%	-12.94%	-41.19%	64.91%	24.49%
Capital Expenditures	-657.46	-668.46	-687.78	-829.94	-1,036.41	-1,113.26
Acquisitions	169.51	137	1.03	-381.73	-244.38	-2,178.04
Change in Investments	38.64	-12.77	-47.97	15.44	-54.16	5.31
Investing Cash Flow	-449.32	-544.23	-734.73	-1,196.23	-1,334.94	-3,285.99
Dividends Paid	-	-328.62	-395.56	-392.46	-351.17	-354.64
Share Issuance / Repurchase	-	0	20.15	6.51	-353.34	-583.93
Debt Issued / Paid	-1,555.09	-1,189.79	-1,118.01	-358.9	-1,265.99	318.55
Other Financing Activities	-595.11	-340.11	-123.95	-279.54	-693.53	153.39
Financing Cash Flow	-2,150.2	-1,858.53	-1,617.36	-1,024.38	-2,664.03	-466.63
Exchange Rate Effect	-45.65	-72.61	-23.16	131.23	-160.37	47.76
Net Cash Flow	-31.9	153.44	-207.87	400.12	73.82	-1,137.91
Free Cash Flow	1,956	1,960	1,480	1,660	3,197	1,454
Free Cash Flow Growth	31.87%	32.49%	-10.84%	-48.09%	119.91%	37.25%
Free Cash Flow Margin	10.04%	10.08%	7.63%	9.42%	17.90%	8.32%
Free Cash Flow Per Share	3.33	3.34	2.52	2.83	5.36	2.37

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).